HK Stock MarketDetailed Quotes
01515 CR MEDICAL
- 4.170
- +0.040+0.97%
Not Open Apr 29 16:08 CST
5.41BMarket Cap19.04P/E (TTM)
4.240High4.040Low2.66MVolume4.110Open4.130Pre Close11.13MTurnover0.21%Turnover Ratio19.04P/E (Static)1.30BShares7.56352wk High0.84P/B5.41BFloat Cap3.66052wk Low0.04Dividend TTM1.30BShs Float16.392Historical High0.037Dividend LFY4.84%Amplitude2.705Historical Low4.189Avg Price500Lot Size0.89%Div YieldTTM0.89%Div Yield LFY
CR MEDICAL Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 16.55%492.92M | ---- | 56.37%422.94M | ---- | -35.32%270.48M | ---- | -22.74%418.19M | ---- | -8.09%541.3M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 8.59%-85.33M | ---- | -20.54%-93.35M | ---- | 3.11%-77.45M | ---- | -23.00%-79.93M | ---- | 2.17%-64.98M | ---- |
| Dividend (income)- adjustment | -19.14%-3.87M | ---- | -16.24%-3.25M | ---- | -6.76%-2.8M | ---- | -398.67%-2.62M | ---- | 77.36%-525K | ---- |
| Attributable subsidiary (profit) loss | -3.08%-90.78M | ---- | -5.40%-88.07M | ---- | -138.94%-83.55M | ---- | -652.65%-34.97M | ---- | -116.39%-4.65M | ---- |
| Impairment and provisions: | 252.24%481.37M | --0 | -61.54%136.66M | --0 | 1,410.26%355.29M | --0 | 1,391.76%23.53M | --0 | 2,326.15%1.58M | --0 |
| -Impairment of property, plant and equipment (reversal) | 41,231.18%210.79M | ---- | --510K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | 1,036.84%216K | ---- | --19K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | 30.18%141.02M | ---- | --108.32M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | 365.18%129.35M | ---- | -92.17%27.81M | ---- | 1,410.26%355.29M | ---- | 1,391.76%23.53M | ---- | 2,326.15%1.58M | ---- |
| Revaluation surplus: | 393.48%16.52M | --0 | -120.53%-5.63M | --0 | 9.06%27.42M | --0 | 86.35%25.14M | --0 | 370.25%13.49M | --0 |
| -Other fair value changes | 393.48%16.52M | ---- | -120.53%-5.63M | ---- | 9.06%27.42M | ---- | 86.35%25.14M | ---- | 370.25%13.49M | ---- |
| Asset sale loss (gain): | 144.43%2.39M | --0 | ---5.37M | --0 | --0 | --0 | --0 | --0 | 200.00%795K | --0 |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---5.68M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 671.84%2.39M | ---- | --309K | ---- | ---- | ---- | ---- | ---- | -49.04%795K | ---- |
| Depreciation and amortization: | 28.67%595.58M | --0 | 153.10%462.87M | --0 | 61.29%182.88M | --0 | 78.15%113.38M | --0 | -12.80%63.64M | --0 |
| -Depreciation | 25.98%604.34M | ---- | 172.28%479.71M | ---- | 67.02%176.19M | ---- | 134.96%105.49M | ---- | -7.60%44.89M | ---- |
| -Amortization of intangible assets | -2.60%6.52M | ---- | 0.01%6.69M | ---- | -15.25%6.69M | ---- | -57.88%7.9M | ---- | -10.82%18.75M | ---- |
| -Other depreciation and amortization | 35.07%-15.28M | ---- | ---23.53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Financial expense | 85.30%131.84M | ---- | 298.95%71.15M | ---- | 2.55%17.83M | ---- | 2.65%17.39M | ---- | 120.00%16.94M | ---- |
| Exchange Loss (gain) | -51.10%77.69M | ---- | 692.87%158.88M | ---- | 39.53%-26.8M | ---- | -464.48%-44.31M | ---- | -28.33%12.16M | ---- |
| Special items | ---- | ---- | -81.02%1.92M | ---- | 454.24%10.11M | ---- | -121.62%-2.85M | ---- | 348.42%13.2M | ---- |
| Operating profit before the change of operating capital | 52.85%1.62B | --0 | 57.22%1.06B | --0 | 55.54%673.41M | --0 | -26.99%432.94M | --0 | -1.94%592.95M | --0 |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 476.00%65.18M | ---- | -8,316.11%-17.34M | ---- | 100.91%211K | ---- | -247.77%-23.29M | ---- | 142.28%15.76M | ---- |
| Accounts receivable (increase)decrease | -38.05%-275.31M | ---- | -245.02%-199.43M | ---- | 48.30%137.52M | ---- | 174.59%92.73M | ---- | -5.34%-124.32M | ---- |
| Accounts payable increase (decrease) | -153.02%-64.25M | ---- | 212.14%121.17M | ---- | -144.84%-108.06M | ---- | 517.85%240.97M | ---- | 2,368.48%39M | ---- |
| prepayments (increase)decrease | ---- | ---- | ---- | ---- | 17,023.27%132.34M | ---- | -173.22%-782K | ---- | 300.75%1.07M | ---- |
| Cash from business operations | 34.40%1.31B | --0 | 18.04%970.97M | --0 | 12.32%822.58M | --0 | 40.35%732.35M | --0 | 6.24%521.81M | --0 |
| Other taxs | -13.60%-163.4M | ---- | -5.77%-143.84M | ---- | -38.38%-135.99M | ---- | 40.03%-98.27M | ---- | -0.73%-163.88M | ---- |
| Interest received - operating | 46.78%53.51M | ---- | 52.90%36.46M | ---- | 148.04%23.84M | ---- | 18.33%9.61M | ---- | 42.78%8.12M | ---- |
| Special items of business | -599.06%-38.94M | ---- | 160.75%7.8M | ---- | -25.69%-12.84M | ---- | -284.71%-10.22M | ---- | -106.52%-2.66M | ---- |
| Net cash from operations | 38.39%1.2B | 459.47%540.44M | 21.56%863.59M | -24.18%96.6M | 10.37%710.43M | -43.40%127.41M | 75.85%643.69M | 3,067.93%225.11M | 9.55%366.05M | -93.36%7.11M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 1,990.00%92.75M | 19.14%3.87M | 58.78%4.44M | 16.24%3.25M | 6.76%2.8M | 6.76%2.8M | 398.67%2.62M | 398.67%2.62M | -77.36%525K | 29.95%525K |
| Loan receivable (increase) decrease | -40.84%7.39M | -35.23%2.39M | 11.63%12.49M | 54.46%3.69M | -41.87%11.19M | -47.57%2.39M | 113.32%19.25M | 214.00%4.55M | -42.31%9.02M | -54.94%1.45M |
| Decrease in deposits (increase) | -838.55%-25.41M | 369.59%3.32M | -73.25%3.44M | -107.06%-1.23M | 173.85%12.86M | --17.42M | ---17.42M | ---- | ---- | -117.62%-19.64M |
| Sale of fixed assets | 797.10%54.98M | 104.70%7.93M | 192.41%6.13M | 86.60%3.87M | -71.67%2.1M | 177.78%2.08M | 99.43%7.4M | 105.79%747K | 29.86%3.71M | --363K |
| Purchase of fixed assets | -4.38%-486.68M | -78.22%-193.69M | -134.98%-466.28M | -46.22%-108.68M | 5.30%-198.43M | -328.43%-74.33M | -476.23%-209.55M | -85.00%-17.35M | 36.87%-36.37M | 66.76%-9.38M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | -260.30%-28.82M | ---- | ---8M | ---- | ---- | ---- |
| Sale of subsidiaries | -75,360,740.00%-3.77B | ---- | --5K | --50K | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | 126.70%173.92M | 120.25%173.92M | -656.53%-651.28M | -832.63%-858.76M | 39,108.67%117.03M | --117.22M | 88.70%-300K | ---- |
| Recovery of cash from investments | -25.35%3.56B | 28.19%2.65B | 12.02%4.76B | 34.19%2.07B | -38.09%4.25B | -59.95%1.54B | 18.42%6.87B | 41.00%3.85B | 15.58%5.8B | 2.64%2.73B |
| Cash on investment | 38.60%-2.67B | -18.19%-2.53B | 18.51%-4.35B | 25.15%-2.14B | 20.50%-5.34B | 40.30%-2.86B | -19.07%-6.72B | -75.83%-4.78B | -16.33%-5.64B | -4.99%-2.72B |
| Other items in the investment business | 197.15%620.19M | --448.04M | -18,847.90%-638.37M | ---- | --3.41M | 150.49%4.09M | ---- | -134.25%-8.09M | 7,973.00%23.62M | 13.36%23.62M |
| Net cash from investment operations | -430.77%-2.62B | 5,417.64%398.71M | 74.48%-494.02M | 100.33%7.23M | -3,307.23%-1.94B | -166.31%-2.22B | -61.61%60.37M | -10,833.53%-832.6M | -55.76%157.24M | -95.58%7.76M |
| Net cash before financing | -486.12%-1.43B | 804.55%939.14M | 130.15%369.57M | 104.97%103.82M | -274.08%-1.23B | -244.03%-2.09B | 34.54%704.05M | -4,187.24%-607.49M | -24.11%523.29M | -94.74%14.86M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -35.52%5.55B | -55.85%1.94B | 41.85%8.61B | 47.96%4.39B | 1,233.95%6.07B | 2,139.09%2.97B | 386.18%455.24M | 1,421.75%132.59M | -69.16%93.64M | -78.66%8.71M |
| Refund | 33.03%-5.77B | 56.98%-1.9B | -69.39%-8.62B | -122.59%-4.41B | -1,513.32%-5.09B | ---1.98B | -1,738.65%-315.44M | ---- | -40,747.62%-17.16M | -5,452.10%-17.16M |
| Interest paid - financing | -106.16%-116.27M | -302.93%-54.49M | -185.20%-56.4M | -65.06%-13.52M | -39.06%-19.77M | 11.78%-8.19M | 15.52%-14.22M | -86.82%-9.29M | -147.54%-16.83M | -219.06%-4.97M |
| Dividends paid - financing | 57.33%-55.53M | -2,085.82%-11.87M | -30.20%-130.14M | 99.40%-543K | 20.49%-99.96M | 21.34%-91.08M | 11.72%-125.73M | -958.89%-115.78M | -9.83%-142.42M | 1.58%-10.93M |
| Absorb investment income | ---- | ---- | ---- | ---- | -65.46%544K | ---- | 1.29%1.58M | -24.03%980K | -27.30%1.56M | 29.00%1.29M |
| Other items of the financing business | -50.57%-46.47M | -26.37%-10.79M | -67.11%-30.86M | -29.95%-8.54M | -109.61%-18.47M | -677.63%-6.57M | -121.89%-8.81M | -102.10%-845K | 118.81%40.25M | --40.25M |
| Net cash from financing operations | -95.40%-437.08M | 17.57%-36.5M | -126.44%-223.69M | -105.03%-44.29M | 11,559.71%845.96M | 11,387.69%879.84M | 81.98%-7.38M | -55.44%7.66M | 8.39%-40.97M | 264.09%17.19M |
| Effect of rate | -94.84%141K | -60.00%698K | 16.84%2.73M | 139.91%1.75M | 253.85%2.34M | -461.02%-4.37M | -441.28%-1.52M | 256.87%1.21M | -112.37%-281K | -236.88%-772K |
| Net Cash | -1,377.84%-1.86B | 1,416.10%902.64M | 138.42%145.88M | 104.92%59.54M | -154.50%-379.66M | -101.74%-1.21B | 44.44%696.67M | -1,971.48%-599.83M | -25.20%482.33M | -88.22%32.05M |
| Begining period cash | 5.04%3.1B | 5.04%3.1B | 9.26%2.95B | 9.26%2.95B | 34.65%2.7B | 34.65%2.7B | 31.63%2.01B | 31.63%2.01B | 73.78%1.52B | 73.78%1.52B |
| Cash at the end | -60.13%1.24B | 32.88%4B | 33.39%3.1B | 102.61%3.01B | -13.97%2.32B | 5.63%1.49B | 34.65%2.7B | -9.51%1.41B | 31.63%2.01B | 35.28%1.56B |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | KPMG | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg